CLINICAL_TRIALS
trial_result
· 2015-10-14
Clinical Trial Update: Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years [Phase 2]
Summary
Phase 2 crossover trial completed to assess whether dry powder mannitol improves lung function in children and adolescents with cystic fibrosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Syntara | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED